Browsing “Market AccessMarket Access | EVERSANA”

Methodology for Predicting Switching Behaviors in Patients

Patient and hub services represent a significant and often ineffective spend surrounding overall patient support. How can we use data and analytics to build better patient services programs that predict next best actions and achieve improved patient engagement and outcomes across the treatment journey? As the industry continues its shift to value-based care, this challenge […]

Is BeNeLuxA Equipped for a Zolgensma Assessment?

The BeNeLuxA initiative is set to take on Zolgensma (onasemnogene abeparvovec), an innovative gene therapy for children under two years old with spinal muscular atrophy (SMA), which was granted conditional approval for use in Europe in May. Belgium, Ireland, and the Netherlands will undertake a joint health technology assessment (HTA) of Zolgensma as part of […]

Where Health Systems are in the Shift to Value: Four Categories

One could make the argument that there are four situational categories under which all health systems now fall on the journey toward more value-based care and away from the fee-for-service model. Assisting health systems in successfully transitioning to value-based care and delivering improved clinical and financial outcomes for their patient populations depends on very different […]

ICER’s Alternative Pricing Models: New Threats to Biopharmaceutical’s Profitability and Innovation

The Institute for Clinical and Economic Review (ICER) has been very responsive to the current public health pandemic, from adjusting their review timelines to assessing COVID-19 impact on drug pricing and patient access. Within a few days of Gilead’s remdesivir gaining emergency approval by the U.S. Food and Drug Administration (FDA), ICER has published an analysis on […]

Pricentric ONE Newsletter | June 2020

Good news, this month’s issue of the Pricentric Newsletter is now available for download. Fill out the form below to download the Newsletter!

COVID-19’s Impact on Brand Access

The current public health pandemic is impacting healthcare stakeholders from doctors and nurses in the frontlines to payers and PBMs. EVERSANA™ is monitoring the constant changes to access and benefit consideration, tracking payer responses, and key trends that may impact your brand access strategy. According to recent research released by Health Strategies Insights by EVERSANA™, […]

How COVID-19 will Change the Patient Journey, Reimbursement, and Care Delivery

Value-based care has led to much change in healthcare over the years, and COVID-19 is pushing change faster and even further. These changes forced by COVID-19 will have long-term effects on every aspect of care delivery; current healthcare tools and programs such as clinical pathways need to adjust to these changes to continue being helpful. […]

Brand Access Marketplace Dynamics: Respiratory

This summary provides highlights from robust longitudinal insights reports released throughout the year and available at our INTELLICENTER® portal. The Brand Access Marketplace Dynamics reports identify current and future access landscapes providing insights to support effective identification of opportunities and risks for Respiratory brands. Get answers to key questions such as: What level of influence […]

Brand Access Marketplace Dynamics: Multiple Sclerosis

This summary provides highlights from robust longitudinal insights reports released throughout the year and available at our INTELLICENTER® portal. The Brand Access Marketplace Dynamics reports identify current and future access landscapes providing insights to support effective identification of opportunities and risks for Multiple Sclerosis brands. Get answers to key questions such as: What level of […]

Brand Access Marketplace Dynamics: HIV

This summary provides highlights from robust longitudinal insights reports released throughout the year and available at our INTELLICENTER® portal. The Brand Access Marketplace Dynamics reports identify current and future access landscapes providing insights to support effective identification of opportunities and risks for HIV brands. Get answers to key questions such as: What level of influence […]